CN115337234A - 一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 - Google Patents
一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 Download PDFInfo
- Publication number
- CN115337234A CN115337234A CN202210803428.4A CN202210803428A CN115337234A CN 115337234 A CN115337234 A CN 115337234A CN 202210803428 A CN202210803428 A CN 202210803428A CN 115337234 A CN115337234 A CN 115337234A
- Authority
- CN
- China
- Prior art keywords
- extract
- oil
- lipstick
- accounts
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 230000008439 repair process Effects 0.000 title claims abstract description 11
- 230000003712 anti-aging effect Effects 0.000 title description 2
- 239000000284 extract Substances 0.000 claims abstract description 88
- 239000003921 oil Substances 0.000 claims abstract description 64
- 235000019198 oils Nutrition 0.000 claims abstract description 64
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 55
- 244000294611 Punica granatum Species 0.000 claims abstract description 42
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 42
- 235000008995 european elder Nutrition 0.000 claims abstract description 31
- 229930182558 Sterol Natural products 0.000 claims abstract description 29
- 150000003432 sterols Chemical class 0.000 claims abstract description 29
- 235000003702 sterols Nutrition 0.000 claims abstract description 29
- 235000003142 Sambucus nigra Nutrition 0.000 claims abstract description 27
- 240000006028 Sambucus nigra Species 0.000 claims abstract description 27
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 22
- 244000237986 Melia azadirachta Species 0.000 claims abstract description 20
- 235000013500 Melia azadirachta Nutrition 0.000 claims abstract description 20
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 18
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 12
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 12
- 229940057910 shea butter Drugs 0.000 claims abstract description 12
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 11
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims abstract description 11
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 11
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000001168 astaxanthin Substances 0.000 claims abstract description 11
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 11
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 11
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 11
- 235000013871 bee wax Nutrition 0.000 claims abstract description 11
- 239000012166 beeswax Substances 0.000 claims abstract description 11
- 239000004204 candelilla wax Substances 0.000 claims abstract description 11
- 235000013868 candelilla wax Nutrition 0.000 claims abstract description 11
- 229940073532 candelilla wax Drugs 0.000 claims abstract description 11
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 11
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 claims abstract description 11
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 11
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 11
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 11
- 229960001295 tocopherol Drugs 0.000 claims abstract description 11
- 239000011732 tocopherol Substances 0.000 claims abstract description 11
- 229930003799 tocopherol Natural products 0.000 claims abstract description 11
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 11
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 11
- 150000002339 glycosphingolipids Chemical class 0.000 claims abstract description 10
- 241001673966 Magnolia officinalis Species 0.000 claims abstract description 9
- 229940084847 rosa damascena flower extract Drugs 0.000 claims abstract description 8
- 239000010487 meadowfoam seed oil Substances 0.000 claims abstract description 5
- 229940092738 beeswax Drugs 0.000 claims abstract description 3
- 229940060184 oil ingredients Drugs 0.000 claims abstract description 3
- 244000241257 Cucumis melo Species 0.000 claims abstract 4
- 238000002156 mixing Methods 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 30
- 238000010438 heat treatment Methods 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 20
- 239000008240 homogeneous mixture Substances 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 14
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 12
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 12
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 12
- 244000037433 Pongamia pinnata Species 0.000 claims description 12
- 235000004599 Pongamia pinnata Nutrition 0.000 claims description 12
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 12
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 12
- 229940074393 chlorogenic acid Drugs 0.000 claims description 12
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 12
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 12
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 12
- 239000000811 xylitol Substances 0.000 claims description 12
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 12
- 229960002675 xylitol Drugs 0.000 claims description 12
- 235000010447 xylitol Nutrition 0.000 claims description 12
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000005360 mashing Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 230000002441 reversible effect Effects 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 238000000465 moulding Methods 0.000 claims description 5
- 241000208829 Sambucus Species 0.000 claims description 4
- 235000018735 Sambucus canadensis Nutrition 0.000 claims description 4
- 235000007123 blue elder Nutrition 0.000 claims description 4
- 235000007124 elderberry Nutrition 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 240000006555 Chamaerops humilis Species 0.000 claims 1
- 235000017788 Cydonia oblonga Nutrition 0.000 claims 1
- 241001521402 Maackia <angiosperm> Species 0.000 claims 1
- 244000181025 Rosa gallica Species 0.000 claims 1
- 239000003208 petroleum Substances 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 4
- 241000238578 Daphnia Species 0.000 abstract description 2
- 239000007934 lip balm Substances 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 24
- 230000000694 effects Effects 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 15
- 239000000523 sample Substances 0.000 description 14
- 239000004359 castor oil Substances 0.000 description 10
- 235000019438 castor oil Nutrition 0.000 description 10
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 206010051246 Photodermatosis Diseases 0.000 description 8
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 7
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 7
- 241000219112 Cucumis Species 0.000 description 7
- 230000006750 UV protection Effects 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 7
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 7
- 239000011280 coal tar Substances 0.000 description 6
- 210000001626 skin fibroblast Anatomy 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 230000002688 persistence Effects 0.000 description 5
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 244000261559 Smilax china Species 0.000 description 4
- 235000000485 Smilax china Nutrition 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 210000000440 neutrophil Anatomy 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 241000252212 Danio rerio Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 240000009022 Smilax rotundifolia Species 0.000 description 3
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 208000007287 cheilitis Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 235000019865 palm kernel oil Nutrition 0.000 description 3
- 239000003346 palm kernel oil Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- -1 polyethylene Polymers 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000219496 Alnus Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- LKPQNZRGGNOPPU-UHFFFAOYSA-N Karanjin Chemical compound O1C2=C3C=COC3=CC=C2C(=O)C(OC)=C1C1=CC=CC=C1 LKPQNZRGGNOPPU-UHFFFAOYSA-N 0.000 description 2
- JANBLZHPNGBWAO-UHFFFAOYSA-N Karanjin Natural products O1C2=C3OC=CC3=CC=C2C(=O)C(OC)=C1C1=CC=CC=C1 JANBLZHPNGBWAO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 241001098657 Pterois Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 229940045731 elderberry fruit Drugs 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 2
- 229960003656 ricinoleic acid Drugs 0.000 description 2
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000001040 synthetic pigment Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 241001350637 Alnus cremastogyne Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- 241000846171 Cremastra Species 0.000 description 1
- 241000594402 Damnacanthus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021567 Impulsive behaviour Diseases 0.000 description 1
- 235000006662 Lansium Nutrition 0.000 description 1
- 241001156382 Lansium Species 0.000 description 1
- 208000020358 Learning disease Diseases 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- MIBATSHDJRIUJK-ROJLCIKYSA-N Neferine Chemical compound C1=CC(OC)=CC=C1C[C@@H]1C2=CC(OC=3C(=CC=C(C[C@@H]4C5=CC(OC)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C MIBATSHDJRIUJK-ROJLCIKYSA-N 0.000 description 1
- MIBATSHDJRIUJK-UHFFFAOYSA-N Neferine Natural products C1=CC(OC)=CC=C1CC1C2=CC(OC=3C(=CC=C(CC4C5=CC(OC)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C MIBATSHDJRIUJK-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000123113 Phellinus igniarius Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000006322 Sambucus chinensis Species 0.000 description 1
- 235000010426 Sambucus chinensis Nutrition 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000205578 Thalictrum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229940056635 azadirachta indica seed extract Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002725 coal tar dye Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 231100000722 genetic damage Toxicity 0.000 description 1
- 231100000024 genotoxic Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 238000010630 lipid peroxidation (MDA) assay Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229940082450 magnolia officinalis bark extract Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003188 neurobehavioral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000001325 yolk sac Anatomy 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
- A61Q1/06—Lipsticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/001—Preparations for care of the lips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Insects & Arthropods (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
本发明属于口红的技术领域，具体涉及一种抗光老的深度修护100％纯生物来源的口红及其制备工艺。所述口红的组成原料如下：石榴甾醇类提取物、白池花籽油、毛瑞榈果油、水黄皮籽提取物、蜂蜡、小烛树蜡、牛油果树果脂油、大裂叶五桤木籽油、虾青素、印度楝花提取物、印度楝籽提取物、红瓜果提取物、糖鞘脂类、磷脂、胆甾醇、突厥蔷薇花提取物、厚朴树皮提取物、西洋接骨木果油、透明质酸钠以及生育酚；所述口红来源于纯生物，既安全又具有功效，所得口红1)比润唇膏更滋润，与石油口红相当；2)颜色饱和度高、妆容持久度强；3)具有抗蓝光、抗紫外线以及强大修护力的功效。
Description
技术领域
本发明属于口红的技术领域，具体涉及一种抗光老的深度修护100％纯生物来源的口红及其制备工艺。
背景技术
口红是一种由蜡、油脂、色素三种元素形成的彩妆产品，为现代女性不可或缺的日用品。而目前市场上超过99％的口红商品，无论在蜡、油脂还是色素的运用选择上，皆采用是有衍生物或人工合成的原料配制而成，如采用石蜡(石油来源)、地蜡(石油来源)、微晶蜡(石油来源)、辛基十二醇(合成油脂)、聚乙烯(石油微塑料)、丁羟甲苯(人工抗氧化剂)以及合成色素(煤焦油)，这些原料非但对人类健康毫无益处，反而在潜移默化中，带来健康风险和危机。
有研究表明，美国环境工作组EWG对711中口红产品进行检查，发现其中发现其中28％的成分与丁羟甲苯、尼龙6(锦纶-6)、氧化铁、聚乙烯和二氧化钛等化学物质的致癌风险有关。它们存在的健康影响，可能包括恶心、痉挛、呕吐、皮疹、关节和骨骼疼痛、口腔溃疡、癌症、遗传损伤、免疫功能障碍、大脑和学习障碍以及冲动和暴力行为。
口红中运用的油脂与蜡，普遍来源于矿油、矿脂、液体石蜡、硅油、微晶蜡以及地蜡等等，多为石油中分馏获得的碳氢化合物的复杂组合。矿物油和蜡经常被发现存在矿物油饱和烃，它具有遗传毒性与致癌性。2011年，医学杂志《Journal of Women’s Health》发布一篇名为“Evidence for cosmeticcs as a source of mineral oil contamination inwomen”的研究，结果表明：人体脂肪组织中的矿物油饱和烃浓度，随着年龄增长、时间推移而累计，不断增加，而化妆品可能是相关的污染源。
口红中运用的人工色素，多为煤焦油来源。1915年9月，日本癌病理学家山城胜三郎(Katsusaburo Yamagiwa)，在对癌症实验研究中，反复使用“煤焦油”涂抹兔子的耳朵，使之产生了癌变，证实了长期涂抹“煤焦油”有皮肤癌风险。1977年，日本发布一则关于《有色化妆品皮炎和煤焦油染料》的研究，结果表明，煤焦油来源的染料，与接触性皮炎的病因密切相关。煤焦油的合成色素含有重金属盐，会在皮肤中沉积毒素，导致皮肤敏感和刺激。
此外，口红普遍采用的其它原料中，2020年，一项关于丁羟甲苯(BHT)导致异常焦虑的研究表明，BHT可以影响多巴胺系统的表达；2021年最新的动物研究表明，口服含有0.025％和0.05％丁羟甲苯(BHT)的天然向日葵油，对大鼠的运动、神经行为活动，以及大脑、心脏和肺的组织病理学变化具有毒性。
还有蓖麻油的使用，由于其优异特性，大约80％以上的国内外宣称“天然”的口红中，蓖麻油为不可割舍的原料之一。在一篇名为《青少年对唇膏中的蓖麻籽油(蓖麻油)的过敏性接触性唇炎》研究中，因为蓖麻油中富含90％蓖麻油酸，它被确认为蓖麻油致敏的最敏感物质，新加坡一家医院对202名唇炎患者进行跟踪研究，72名被诊断为过敏性接触性唇炎，其中29名患者的蓖麻油酸呈阳，表明了蓖麻油可导致过敏性接触性皮炎的概率较大，因此，现有的所谓天然口红中所采用的蓖麻油，存在致敏风险，并不一定安全。
因此，研发一种兼顾安全又功效的100％天然原料配制的纯植物口红尤为关键，对于广大女性群体的健康使用具有重要意义。
发明内容
针对上述问题，本发明的目的在于提供一种抗光老的深度修护100％纯生物来源的口红及其制备工艺。
本发明的技术内容如下：
本发明提供一种抗光老的深度修护100％纯生物来源的口红，所述口红的组成原料如下：石榴甾醇类提取物、白池花籽油、毛瑞榈果油、水黄皮籽提取物(卡兰贾油)、蜂蜡、小烛树蜡、牛油果树果脂油、大裂叶五桤木籽油、虾青素、印度楝花提取物、印度楝籽提取物、红瓜果提取物、糖鞘脂类、磷脂、胆甾醇、突厥蔷薇花提取物、厚朴树皮提取物、西洋接骨木果油、透明质酸钠以及生育酚(维生素E)；
所述白池花籽油中，含有98％以上具有抗氧化作用的长链脂肪酸，其具有优异的稳定性，能够增强口红的抗氧化能力，以及作为优良的润肤剂；
所述毛瑞榈果油，也称布里奇果油，其含有高浓度的天然抗氧剂β-胡萝卜素与生育酚、维生素C2协同，可有效防护光老化和皮肤失水，拥有高超的抵抗强紫外线、抗氧化能力，能够隔绝蓝光；其富含不饱和脂肪酸能够强固皮肤屏障，促进细胞增殖和新生，能够促进弹性纤维、胶原纤维产生和积累；
所述水黄皮籽提取物(卡兰贾油)是一种具有光防护的活性物质，具有天然防晒的功能呢，能够增强产品的光保护功效，扩大紫外光谱，尤其是对UVB的防护；
所述大裂叶五桤木籽油具有美白、抗紫外以及抗衰老活性，能够使得肤色均匀、增加肌肤透明质酸含量，还能够有效增加胶原蛋白密度；同时帮助唇部肌肤深层滋润；
所述牛油果树果脂油中含有生物三萜酯类，具有强大的皮肤修复、舒缓和保护性能，能够抵御UVA+UVB导致的炎症，从而起到抗光老功效；
所述厚朴树皮提取物中含有98％高纯度活性多酚-厚朴多酚和和厚朴酚，具有特殊的、持久的肌肉松弛作用及强的抗菌作用，用于本发明的口红产品中起到舒缓唇纹，抑菌抗炎，以及美白，抗氧化功能，能够实现产品配方稳定。
按重量份数计，所述石榴甾醇类提取物占15～40份、白池花籽油占15～30份、毛瑞榈果油占10～15份、水黄皮籽提取物占10～15份、蜂蜡占10～20份、小烛树蜡占10～15份、牛油果树果脂油占10～20份、大裂叶五桤木籽油占10～15份、虾青素占3～6份、印度楝花提取物占0.1～1份、印度楝籽提取物占0.1～1份、红瓜果提取物占0.1～1份、糖鞘脂类占0.5～1份、磷脂占0.5～1份、胆甾醇占0.5～1份、突厥蔷薇花提取物占0.1～1份、厚朴树皮提取物占0.1～1份、西洋接骨木果油占2～5份、透明质酸钠占0.5～1份以及生育酚占0.1～1份。
所述石榴甾醇类提取物的制备如下：
选取石榴果皮以及石榴籽，置于真空下烘干至水分为5～10％，烘干温度为80～85℃，研磨过筛至80～100目，封装之后，用于间歇式超临界萃取仪萃取，之后分离，得到石榴甾醇类提取物；
所述萃取的温度为40～50℃，压力为35～40MPa；
所述分离的温度为33～38℃，压力为6～10MPa；
所述石榴甾醇类提取物可以替代合成油，具有较强的保湿和增强屏障功能的功效，促进皮肤代谢。
所述西洋接骨木果油的提取工艺为：取西洋接骨木的果实，清洗干净捣碎、以1:(8～10)mg/mL的料液比与木糖醇、绿原酸的混合物混合，进行超声微波处理，冷却至室温之后进行间歇式超临界萃取仪萃取，之后分离，即得到西洋接骨木果油；
所述木糖醇和绿原酸的混合质量比为(3～4)：(4～7)；
所述超声微波处理的条件为微波的频率为600～800MHz，超声的频率为800～1000MHz，反应温度为215～225℃；
所述减压浓缩的压力为0.05～0.08MPa，温度为70～80℃；
所述冷冻干燥的温度条件为-10～0℃；
所述萃取的温度为30～40℃，压力为25～30MPa；
所述分离的温度为30～35℃，压力为10～15MPa。
所述西洋接骨木果提取物的成分包括黄酮类、木脂素以及环烯醚萜类等的活性成分，具有较强的抗氧化和抗炎抑菌功效，对于自由基、DPPH具有很好地清除作用。
本发明还提供了一种抗光老的深度修护100％纯生物来源的口红的制备工艺：
1)将白池花籽油、毛瑞榈果油、水黄皮籽提取物、糖鞘脂类、磷脂、胆甾醇混合，升温至70～80℃进行搅拌加热，得到均质混合物A；
2)将牛油果树果脂油、大裂叶五桤木籽油、印度楝花提取物、印度楝籽提取物、红瓜果提取物、突厥蔷薇花提取物、厚朴树皮提取物混合，升温至80～90℃进行搅拌加热，再降温至70～80℃，缓慢添加透明质酸钠粉末，搅拌均匀，得到均质混合物B；
4)在70～80℃的温度下，将均质混合物A、B混合，缓慢加入蜂蜡、小烛树蜡和生育酚，搅拌均匀，之后降温至60～70℃，缓慢加入石榴甾醇类提取物、西洋接骨木果油和虾青素，搅拌均匀之后倒模成形，即得到口红产品。
本发明的有益效果如下：
本发明的抗光老的深度修护100％纯生物来源的口红及其制备工艺，所述纯生物是指本发明的口红采用由植物来源、动物来源、生物发酵来源的原料配制而成，不添加人工合成或石油衍生成分，也没有采用危险的植物原料(如蓖麻油/紫草油)，无毒无害，既安全又具有抗光老、深度修护的功效。通过本发明的纯生物来源的原料配方以及制备工艺，使得所得口红1)比润唇膏更滋润，与石油口红相当；2)颜色饱和度高、妆容持久度强；3)具有抗蓝光、抗紫外线以及强大修护力的功效。
附图说明
图1为本发明所制备的口红产品对被紫外照射抑制的SOD和GPx活力的增强能力；
图2为本发明所制备的口红产品对被紫外照射MDA含量的降低能力；
图3为本发明所采用的毛瑞榈果油的抗蓝光效果图；
图4为口红产品的抗炎舒缓功效典型图。
具体实施方式
以下通过具体的实施案例以及附图说明对本发明作进一步详细的描述，应理解这些实施例仅用于说明本发明而不用于限制本发明的保护范围，在阅读了本发明之后，本领域技术人员对本发明的各种等价形式的修改均落于本申请所附权利要求所限定。
若无特殊说明，本发明的所有原料和试剂均为常规市场的原料、试剂。
实施例1
一种抗光老的深度修护100％纯生物来源的口红的制备
1)将20份白池花籽油、10份毛瑞榈果油、13份水黄皮籽提取物、0.5份糖鞘脂类、1份磷脂、0.6份胆甾醇混合，升温至75℃进行搅拌加热，得到均质混合物A；
2)将20份牛油果树果脂油、12份大裂叶五桤木籽油、0.8份印度楝花提取物、0.5份印度楝籽提取物、1份红瓜果提取物、0.1份突厥蔷薇花提取物、0.5份厚朴树皮提取物混合，升温至85℃进行搅拌加热，再降温至75℃，缓慢添加0.8份透明质酸钠粉末，搅拌均匀，得到均质混合物B；
4)在75℃的温度下，将均质混合物A、B混合，缓慢加入20份蜂蜡、13份小烛树蜡和0.3份生育酚，搅拌均匀，之后降温至65℃，缓慢加入40份石榴甾醇类提取物、2份西洋接骨木果油和3份虾青素，搅拌均匀之后倒模成形，即得到口红产品；
所述石榴甾醇类提取物的制备如下：选取石榴果皮以及石榴籽1000g，置于真空下烘干至水分为5～8％，烘干温度为83℃，研磨过筛至90目，封装之后，用于间歇式超临界萃取仪萃取，萃取的温度为45℃，压力为37MPa，之后分离，温度为35℃，压力为8MPa，得到石榴甾醇类提取物23g；
所述西洋接骨木果油的提取工艺为：取西洋接骨木的果实1000g，清洗干净捣碎、以1:9mg/mL的料液比与木糖醇、绿原酸的混合物混合，进行超声微波处理，微波的频率为700MHz，超声的频率为900MHz，反应温度为220℃，冷却至室温之后进行间歇式超临界萃取仪萃取，温度为35℃，压力为27MPa，之后分离，温度为33℃，压力为13MPa，即得到西洋接骨木果油55.3g；
所述木糖醇和绿原酸的混合质量比为3:5。
实施例2
一种抗光老的深度修护100％纯生物来源的口红的制备
1)将15份白池花籽油、20份毛瑞榈果油、10份水黄皮籽提取物、0.6份糖鞘脂类、0.8份磷脂、0.5份胆甾醇混合，升温至70℃进行搅拌加热，得到均质混合物A；
2)将10份牛油果树果脂油、10份大裂叶五桤木籽油、1份印度楝花提取物、0.3份印度楝籽提取物、0.5份红瓜果提取物、0.5份突厥蔷薇花提取物、0.7份厚朴树皮提取物混合，升温至80℃进行搅拌加热，再降温至70℃，缓慢添加0.6份透明质酸钠粉末，搅拌均匀，得到均质混合物B；
4)在70℃的温度下，将均质混合物A、B混合，缓慢加入12份蜂蜡、15份小烛树蜡和0.1份生育酚，搅拌均匀，之后降温至60℃，缓慢加入15份石榴甾醇类提取物、5份西洋接骨木果油和5份虾青素，搅拌均匀之后倒模成形，即得到口红产品；
所述石榴甾醇类提取物的制备如下：选取石榴果皮以及石榴籽1000g，置于真空下烘干至水分为5～8％，烘干温度为80℃，研磨过筛至80目，封装之后，用于间歇式超临界萃取仪萃取，萃取的温度为40℃，压力为35MPa，之后分离，温度为33℃，压力为6MPa，得到石榴甾醇类提取物24.5g；
所述西洋接骨木果油的提取工艺为：取西洋接骨木的果实1000g，清洗干净捣碎、以1:8mg/mL的料液比与木糖醇、绿原酸的混合物混合，进行超声微波处理，微波的频率为600MHz，超声的频率为800MHz，反应温度为215℃，冷却至室温之后进行间歇式超临界萃取仪萃取，温度为30℃，压力为25MPa，之后分离，温度为30℃，压力为10MPa，即得到西洋接骨木果油54g；
所述木糖醇和绿原酸的混合质量比为3:4。
实施例3
一种抗光老的深度修护100％纯生物来源的口红的制备
1)将25份白池花籽油、15份毛瑞榈果油、15份水黄皮籽提取物、0.6份糖鞘脂类、0.5份磷脂、1份胆甾醇混合，升温至80℃进行搅拌加热，得到均质混合物A；
2)将15份牛油果树果脂油、15份大裂叶五桤木籽油、0.2份印度楝花提取物、0.1份印度楝籽提取物、0.6份红瓜果提取物、0.6份突厥蔷薇花提取物、1份厚朴树皮提取物混合，升温至90℃进行搅拌加热，再降温至80℃，缓慢添加0.5份透明质酸钠粉末，搅拌均匀，得到均质混合物B；
4)在80℃的温度下，将均质混合物A、B混合，缓慢加入17份蜂蜡、14份小烛树蜡和1份生育酚，搅拌均匀，之后降温至70℃，缓慢加入20份石榴甾醇类提取物、3份西洋接骨木果油和6份虾青素，搅拌均匀之后倒模成形，即得到口红产品；
所述石榴甾醇类提取物的制备如下：选取石榴果皮以及石榴籽1000g，置于真空下烘干至水分为8～10％，烘干温度为85℃，研磨过筛至100目，封装之后，用于间歇式超临界萃取仪萃取，萃取的温度为50℃，压力为40MPa，之后分离，温度为38℃，压力为10MPa，得到石榴甾醇类提取物26.7g；
所述西洋接骨木果油的提取工艺为：取西洋接骨木的果实1000g，清洗干净捣碎、以1:10mg/mL的料液比与木糖醇、绿原酸的混合物混合，进行超声微波处理，微波的频率为800MHz，超声的频率为1000MHz，反应温度为225℃，冷却至室温之后进行间歇式超临界萃取仪萃取，温度为40℃，压力为30MPa，之后分离，温度为35℃，压力为15MPa，即得到西洋接骨木果油53.6g；
所述木糖醇和绿原酸的混合质量比为4:7。
实施例4
一种抗光老的深度修护100％纯生物来源的口红的制备
1)将30份白池花籽油、16份毛瑞榈果油、14份水黄皮籽提取物、1份糖鞘脂类、0.7份磷脂、0.8份胆甾醇混合，升温至77℃进行搅拌加热，得到均质混合物A；
2)将13份牛油果树果脂油、14份大裂叶五桤木籽油、0.4份印度楝花提取物、1份印度楝籽提取物、0.1份红瓜果提取物、1份突厥蔷薇花提取物、0.1份厚朴树皮提取物混合，升温至86℃进行搅拌加热，再降温至74℃，缓慢添加1份透明质酸钠粉末，搅拌均匀，得到均质混合物B；
4)在74℃的温度下，将均质混合物A、B混合，缓慢加入10份蜂蜡、10份小烛树蜡和0.8份生育酚，搅拌均匀，之后降温至66℃，缓慢加入30份石榴甾醇类提取物、3份西洋接骨木果油和3份虾青素，搅拌均匀之后倒模成形，即得到口红产品；
所述石榴甾醇类提取物的制备如下：选取石榴果皮以及石榴籽1000g，置于真空下烘干至水分为5～10％，烘干温度为84℃，研磨过筛至90目，封装之后，用于间歇式超临界萃取仪萃取，萃取的温度为47℃，压力为38MPa，之后分离，温度为34℃，压力为7MPa，得到石榴甾醇类提取物22.5g；
所述西洋接骨木果油的提取工艺为：取西洋接骨木的果实1000g，清洗干净捣碎、以1:9mg/mL的料液比与木糖醇、绿原酸的混合物混合，进行超声微波处理，微波的频率为750MHz，超声的频率为850MHz，反应温度为220℃，冷却至室温之后进行间歇式超临界萃取仪萃取，温度为34℃，压力为27MPa，之后分离，温度为33℃，压力为13MPa，即得到西洋接骨木果油56g；
所述木糖醇和绿原酸的混合质量比为3:6。
本发明所采用的布里奇果油与其它成分的抗蓝光能力对比：
表1成分的抗蓝光对比
图1为蓝光照射测试，结合表1结果可见，本发明所采用的布里奇果油具有较为优异的抗蓝光能力，将其应用于制备本发明的口红能有效实现抗蓝光。
对比例1
相比实施例1，不添加石榴甾醇类提取物，其它条件不变。
对比例2
相比实施例1，不添加西洋接骨木果油，其它条件不变。
对比例3
相比实施例1，不添加卡兰贾油，其它条件不变。
对比例4
相比实施例1，采用市场购买的石榴(PUNICA GRANATUM)甾醇类，其它条件不变。
对比例5
相比实施例1，采用市场购买的西洋接骨木(SAMBUCUS NIGRA)果提取物，其它条件不变。
对比例6
相比实施例1，不采用毛瑞榈果油(布里奇果油)，其它条件不变。
将本发明的口红进行如下性能测试：
1.安全性测试
选取50位女性，年龄不限，于唇部涂抹本发明实施例所制备的口红，于涂抹之后的3h、6h、12h观察唇部情况，50位女性均未出现唇部不适现象，说明本发明的口红产品是安全的，且适用于广大女性。
2.口红的感官测试
表2口红性能
其中，色泽评分标准：1＝色泽度低；2＝色泽度较低；3＝色泽度一般；4＝色泽度高；滋润度评分标准：1＝滋润度低；2＝滋润度较低；3＝滋润度一般；4＝滋润度高；持久度评分标准：1＝持久度低；2＝持久度较低；3＝持久度一般；4＝持久度高。
由表1结果可见，本发明实施例所制备的口红在色泽度、滋润度和持久度方面效果均较优异。
2.口红的抗氧化测试(DPPH自由基清除实验)
受检样品处理：将口红用无水乙醇稀释至100mg/mL，作为受检样品母液；
检测方法：在96孔板中加入150μL 0.0394mg/mL的DPPH溶液与150μL不同浓度的受检样品混匀，37℃孵育30min后测OD519nm，得出样品对DPPH自由基的清除率。
检测结果如2所示，其为不同浓度受检样品对DPPH自由基的清除率的结果，结果显示12.5～100mg/mL的口红样品对DPPH自由基有明显的清除作用，清除率为14.3～84.5％，表明具有优异的抗氧化能力。
3.口红的抗紫外和抗蓝光测试
3.1抗紫外测试(测试方法参考自论文“甲基莲心碱对UV致人皮肤成纤维细胞氧化损伤的影响”，曹瑾,杨壮群,Abidullah Khan,等)
1)组别设置
将10g实施例1的口红样品溶于2mL DMSO之后加入198mL无水乙醇稀释，制成浓度5％的样品，再稀释5倍得到0.5％、1％的口红样品溶液，备用，对比例2、3和对比例6的口红样品制备同上，浓度为1％。
空白对照组：无口红样品以及紫外线照射；
模型组：仅紫外线照射；
实验组：口红样品+紫外线照射；
对照组：对比例2、3和对比例6的口红样品+紫外线照射。
2)紫外线照射
取唇部皮肤成纤维细胞接种至培养皿中，生长至90％融合时弃去培养皿内的培养液，用PBS清洗2遍后以少量不含胎牛血清的DMEM覆盖细胞，模型组及实验组放置在紫外灯箱内，紫外灯箱由2个UVA灯(辐射剂量为20J/cm2)和1个UVB灯(辐射剂量为40mJ/cm2)组成，辐射距离为20cm，空白对照组放置在无紫外灯箱的相同环境下。
3)细胞内抗氧化酶活力测定
细胞内SOD和GPx活力分别通过试剂盒测定，唇部皮肤成纤维细胞接受紫外灯照射后立即换以不同浓度口红样品的培养基鸡血培养24h，用0.25％胰酶消化制成细胞悬液后1000r/min离心10min，弃去上清液后用1mLPBD重悬，1000r/min离心10min收集细胞，用超声破碎仪破碎细胞制成细胞匀浆，按说明书严格操作，用酶标仪分别在450nm和412处测定吸光值，计算DOS和GPx活力水平。
结果如图1所示，经紫外线照射后的唇部皮肤成纤维细胞的SOD和GPx活力被抑制，而采用本发明的0.5％、1％浓度的口红能够提高被辐射后细胞内被抑制的SOD和GPx活力，对比例2、3和6组的对被抑制的SOD和GPx活力的增强能力较弱。
4)细胞内MDA含量测定
细胞内MDA含量通过试剂盒测定。细胞接受UV照射后立即换以含不同浓度口红样品的培养基继续培养24h，用0.25％胰酶消化制成细胞悬液后1000r/min离心10min，弃去上清液后用1mLPBS重悬，1000r/min离心10min收集细胞，用0.4mL生理盐水重悬细胞制成细胞悬液。按说明书严格操作，用酶标仪在512nm处测定各管吸光值，计算细胞内MDA含量。
结果如图2所示，经紫外线照射后，唇部皮肤成纤维细胞的MDA含量增加，而本发明的0.5％、1％浓度的口红能够降低被辐射后的细胞内的MDA含量，对比例2、3和6组的对MDA含量的降低能力较弱。
表明本发明的口红产品具有一定的抗紫外性能，以及所采用的西洋接骨木果油、卡兰贾油、毛瑞榈果油(布里奇果油)成分对本发明口红产品的抗紫外能力具有促进作用。
3.2抗蓝光测试
将口红产品涂抹于纸面，采用蓝光灯进行照射测试，同图3，结果如表3所示。
表3抗UV和抗蓝光能力
由表3结果可见，本发明实施例所制备的口红具有一定程度的抗蓝光能力。相比实施例，对比例1中没有添加石榴甾醇类提取物，由于石榴甾醇类的主要作用为保湿和屏障修复，缺少石榴甾醇类提取物对口红的抗紫外能力和抗蓝光能力的影响不大；对比例2中没有添加西洋接骨木果油，使得口红产品的抗蓝光能力大大下降；对比例3中没有添加卡兰贾油，由于其具有一定的抗氧化能力、抗强紫外线以及能够隔绝蓝光，因此缺少卡兰贾油，使得口红产品的隔绝蓝光的能力也大大降低；对比例4和对比例5采用市场购买的成分，所制得的口红的抗紫外和抗蓝光的能力均有所降低，以及缺少布里奇果油的对比例6，抗蓝光能力显著降低。
因此，表明本发明的口红产品中，所制备的石榴甾醇类提取物、西洋接骨木果油相比市场购买的能够带来更好抗蓝光能力，所采用的卡兰贾油和布里奇果油对于使得本发明所制备的口红产品的抗蓝光能力具有促进作用。
4.口红的修护功效测试
采用转基因中性粒细胞绿色荧光品系斑马鱼(MPX)处理前后皮肤中性粒细胞数量变化来检测本发明口红产品的抗炎舒缓的修护功效，检测方法如下：
1)用鱼准备：随机选取45尾斑马鱼(MPX)于6孔板中，每孔15尾；
2)添加样品：以0.5％的浓度将样品添加到6孔板中，每孔定容3mL，同时设置模型对照组和正常对照组；
3)造模：用十二烷基苯磺酸钠对模型对照组和样品组进行处理；
4)孵育：将个实验组于28℃条件下避光孵育18h；
5)拍照：每组随机选取10尾斑马鱼在荧光显微镜下拍照并保存图片；
6)数据处理：样品抗炎舒缓功效按以下公式计算：
将实验结果用SPSS进行统计学分析，检测结果表4所示：
表4抗炎舒缓功效
由表4可见，本发明所制备的口红的抗炎舒缓的效果较为显著。
如图4可见，图中曲线为斑马鱼卵黄囊及背部皮肤，曲线区域为中性粒细胞技术区域，可以看出，实施例1的口红样品组的斑马鱼中性粒细胞个数与模型对照组相比由明显减少，样品具有明显的抗炎舒缓功效。
综上可见，本发明所制备的纯生物来源的口红产品，安全、健康、滋润保湿，并且具有一定的抗氧化、抗紫外、抗蓝光和修护、抗炎舒缓的效果。
Claims (9)
1.一种抗光老的深度修护100％纯生物来源的口红，其特征在于，所述口红的组成原料如下：石榴甾醇类提取物、白池花籽油、毛瑞榈果油、水黄皮籽提取物、蜂蜡、小烛树蜡、牛油果树果脂油、大裂叶五桤木籽油、虾青素、印度楝花提取物、印度楝籽提取物、红瓜果提取物、糖鞘脂类、磷脂、胆甾醇、突厥蔷薇花提取物、厚朴树皮提取物、西洋接骨木果油、透明质酸钠以及生育酚。
2.根据权利要求1所述的深度修护100％纯生物来源的口红，其特征在于，按重量份数计，所述石榴甾醇类提取物占15～40份、白池花籽油占15～30份、毛瑞榈果油占10～15份、水黄皮籽提取物占10～15份、蜂蜡占10～20份、小烛树蜡占10～15份、牛油果树果脂油占10～20份、大裂叶五桤木籽油占10～15份、虾青素占3～6份、印度楝花提取物占0.1～1份、印度楝籽提取物占0.1～1份、红瓜果提取物占0.1～1份、糖鞘脂类占0.5～1份、磷脂占0.5～1份、胆甾醇占0.5～1份、突厥蔷薇花提取物占0.1～1份、厚朴树皮提取物占0.1～1份、西洋接骨木果油占2～5份、透明质酸钠占0.5～1份以及生育酚占0.1～1份。
3.根据权利要求1所述的深度修护100％纯生物来源的口红，其特征在于，所述石榴甾醇类提取物的制备如下：
选取石榴果皮以及石榴籽，置于真空下烘干至水分为5～10％，烘干温度为80～85℃，研磨过筛至80～100目，封装之后，用于间歇式超临界萃取仪萃取，之后分离，得到石榴甾醇类提取物。
4.根据权利要求3所述的深度修护100％纯生物来源的口红，其特征在于，所述萃取的温度为40～50℃，压力为35～40MPa；
所述分离的温度为33～38℃，压力为6～10MPa。
5.根据权利要求1所述的深度修护100％纯生物来源的口红，其特征在于，所述西洋接骨木果油的提取工艺为：取西洋接骨木的果实，清洗干净捣碎、以1:(8～10)mg/mL的料液比与木糖醇、绿原酸的混合物混合，进行超声微波处理，冷却至室温之后进行间歇式超临界萃取仪萃取，之后分离，即得到西洋接骨木果油。
6.根据权利要求5所述的深度修护100％纯生物来源的口红，其特征在于，所述木糖醇和绿原酸的混合质量比为(3～4)：(4～7)。
7.根据权利要求5所述的深度修护100％纯生物来源的口红，其特征在于，所述超声微波处理的条件为微波的频率为600～800MHz，超声的频率为800～1000MHz，反应温度为215～225℃；
所述减压浓缩的压力为0.05～0.08MPa，温度为70～80℃；
所述冷冻干燥的温度条件为-10～0℃。
8.根据权利要求5所述的深度修护100％纯生物来源的口红，其特征在于，所述萃取的温度为30～40℃，压力为25～30MPa；
所述分离的温度为30～35℃，压力为10～15MPa。
9.一种抗光老的深度修护100％纯生物来源的口红的制备工艺，其特征在于，包括如下步骤：
1)将白池花籽油、毛瑞榈果油、水黄皮籽提取物、糖鞘脂类、磷脂、胆甾醇混合，升温至70～80℃进行搅拌加热，得到均质混合物A；
2)将牛油果树果脂油、大裂叶五桤木籽油、印度楝花提取物、印度楝籽提取物、红瓜果提取物、突厥蔷薇花提取物、厚朴树皮提取物混合，升温至80～90℃进行搅拌加热，再降温至70～80℃，缓慢添加透明质酸钠粉末，搅拌均匀，得到均质混合物B；
4)在70～80℃的温度下，将均质混合物A、B混合，缓慢加入蜂蜡、小烛树蜡和生育酚，搅拌均匀，之后降温至60～70℃，缓慢加入石榴甾醇类提取物、西洋接骨木果油和虾青素，搅拌均匀之后倒模成形，即得到口红产品。
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210803428.4A CN115337234A (zh) | 2022-07-07 | 2022-07-07 | 一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 |
| CN202310831271.0A CN116869879B (zh) | 2022-07-07 | 2023-07-06 | 一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210803428.4A CN115337234A (zh) | 2022-07-07 | 2022-07-07 | 一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115337234A true CN115337234A (zh) | 2022-11-15 |
Family
ID=83947905
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210803428.4A Withdrawn CN115337234A (zh) | 2022-07-07 | 2022-07-07 | 一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 |
| CN202310831271.0A Active CN116869879B (zh) | 2022-07-07 | 2023-07-06 | 一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310831271.0A Active CN116869879B (zh) | 2022-07-07 | 2023-07-06 | 一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN115337234A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106798698A (zh) * | 2017-03-03 | 2017-06-06 | 北京华奥光程化妆品有限公司 | 一种皮肤保湿淡化细纹的植物提取物及其制备方法和应用 |
| CN106999378A (zh) * | 2014-10-06 | 2017-08-01 | 医疗品牌研究有限公司 | 包含基于木槿花和布里奇果油的组合物的皮肤用试剂盒 |
| CN110101628A (zh) * | 2019-04-03 | 2019-08-09 | 广州曼知生物科技有限公司 | 一种不含蓖麻油的口红 |
| CN110123708A (zh) * | 2019-04-25 | 2019-08-16 | 广州澳梓美生物科技有限公司 | 一种具有补水、保湿、舒缓、抗氧化作用的护肤品及其制备方法和应用 |
| CN110123691A (zh) * | 2019-05-24 | 2019-08-16 | 广州维真渼生物科技有限公司 | 透白光彩隔离乳及其制备方法 |
| CN110269825A (zh) * | 2019-07-25 | 2019-09-24 | 上海欧润化妆品有限公司 | 一种纯天然唇膏及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070281044A1 (en) * | 2006-06-02 | 2007-12-06 | Mueller Mark J | Use of cold-pressed edible seed oils, flours, and/or blends thereof as anti-inflammatory and cox-2 inhibitory agents |
| CN106581687A (zh) * | 2016-12-22 | 2017-04-26 | 吉林大学 | 以乳清蛋白为基质的桃柁酚抗菌纳米水凝胶及其制备方法 |
| CN109589298A (zh) * | 2019-01-21 | 2019-04-09 | 水母娘娘海洋生物科技有限公司 | 一种卤虫卵空壳分散液及其制备工艺与应用 |
| CN112294724A (zh) * | 2020-11-18 | 2021-02-02 | 美丽链接生物科技研究院(广东)有限公司 | 一种祛痘功效的冰淇淋状磨砂膏 |
| CN112494369A (zh) * | 2020-12-09 | 2021-03-16 | 珠海伊斯佳科技股份有限公司 | 一种沐浴油及其制备方法 |
-
2022
- 2022-07-07 CN CN202210803428.4A patent/CN115337234A/zh not_active Withdrawn
-
2023
- 2023-07-06 CN CN202310831271.0A patent/CN116869879B/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106999378A (zh) * | 2014-10-06 | 2017-08-01 | 医疗品牌研究有限公司 | 包含基于木槿花和布里奇果油的组合物的皮肤用试剂盒 |
| CN106798698A (zh) * | 2017-03-03 | 2017-06-06 | 北京华奥光程化妆品有限公司 | 一种皮肤保湿淡化细纹的植物提取物及其制备方法和应用 |
| CN110101628A (zh) * | 2019-04-03 | 2019-08-09 | 广州曼知生物科技有限公司 | 一种不含蓖麻油的口红 |
| CN110123708A (zh) * | 2019-04-25 | 2019-08-16 | 广州澳梓美生物科技有限公司 | 一种具有补水、保湿、舒缓、抗氧化作用的护肤品及其制备方法和应用 |
| CN110123691A (zh) * | 2019-05-24 | 2019-08-16 | 广州维真渼生物科技有限公司 | 透白光彩隔离乳及其制备方法 |
| CN110269825A (zh) * | 2019-07-25 | 2019-09-24 | 上海欧润化妆品有限公司 | 一种纯天然唇膏及其制备方法 |
Non-Patent Citations (3)
| Title |
|---|
| 刘慧民等 * |
| 赵亚平: "超临界CO2萃取分离植物甾醇的研究" * |
| 高晓旭: "接骨木果油的超临界CO2流体萃取及其微胶囊技术研究" * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116869879A (zh) | 2023-10-13 |
| CN116869879B (zh) | 2024-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111557875B (zh) | 一种抗光污染、光损伤的护肤组合物及其制备方法和应用 | |
| KR101990003B1 (ko) | 모란 혼합 추출물을 함유한 항산화 및 피부미백용 화장료 조성물의 제조방법 및 이를 포함하는 화장료 조성물 | |
| JPH0717847A (ja) | 皮膚外用剤 | |
| KR101452770B1 (ko) | 유산균 발효액을 함유하는 항산화, 미백 및 주름개선 효과를 갖는 화장료 조성물 | |
| KR100443588B1 (ko) | 목단피추출물과 자귀나무추출물을 함유하는 노화방지화장료 조성물 | |
| KR101711002B1 (ko) | 인삼잎추출물 제조방법 및 이를 유효성분으로 함유하는 화장료 조성물 | |
| KR101026879B1 (ko) | 피부주름개선용 화장료 조성물의 제조방법 | |
| AU2021274894B2 (en) | Moringa peregrina seed extract rich in 2,5-diformylfuran, process for obtaining same and use thereof in cosmetic compositions | |
| KR102465138B1 (ko) | 약용식물 혼합 발효추출물(Phytoestrogenbiom)을 유효성분으로 포함하는 화장료 조성물 | |
| KR101415996B1 (ko) | 화산석 송이를 함유하는 화장료 조성물 | |
| KR20160004568A (ko) | 인삼잎추출물 제조방법 및 이를 유효성분으로 함유하는 화장료 조성물 | |
| JP7075177B2 (ja) | 化粧料 | |
| KR101427573B1 (ko) | 인삼 열매 추출물을 유효성분으로 함유하는 여드름 피부 개선용 화장료 조성물 | |
| KR101969684B1 (ko) | 천연 미세침 분말과 천연 복합 추출물을 유효성분으로 포함하는 주름개선 및 모공축소 기능의 화장료 조성물 | |
| KR100903654B1 (ko) | 하고초 추출물과 아데노신을 함유하는 화장료 조성물 | |
| CN115337234A (zh) | 一种抗光老的深度修护100%纯生物来源的口红及其制备工艺 | |
| KR20120092229A (ko) | 조직 배양한 유채와 석류, 산삼의 발효 추출물을 유효성분으로 하는 화장료 조성물 | |
| CN104470488B (zh) | Dickkopf‑1表达调节组合物及其用途 | |
| KR101757790B1 (ko) | 황숙종 인삼 추출물을 함유하는 피부 외용제 조성물 | |
| KR20160003918A (ko) | 한약재 추출물을 포함하는 피부 탄력 증진 또는 주름 개선용 화장료 조성물 | |
| KR101550275B1 (ko) | 거북으로부터 아교를 제조하는 방법 및 그 아교를 함유하는 피부개선용 화장료 조성물 | |
| KR102099251B1 (ko) | 불등풀가사리를 포함하는 해조혼합 발효물 및 이를 유효성분으로 함유하는 화장료 조성물 | |
| KR100552269B1 (ko) | 금등화 추출물 또는 비자 추출물로부터 선택된 1종 이상을 주요 활성성분으로 함유하는 피부외용 화장료 조성물 | |
| KR101427574B1 (ko) | 인삼 열매 추출물을 유효성분으로 함유하는 항염증용 화장료 조성물 | |
| CN116035975B (zh) | 一种牡丹花水在护肤品中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20221115 |
|
| WW01 | Invention patent application withdrawn after publication |